(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.
Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285.
P L
PL
Ornstein
M B
MB
Arnold
N K
NK
Augenstein
D
D
Lodge
J D
JD
Leander
D D
DD
Schoepp
D000818:Animals; D018691:Excitatory Amino Acid Antagonists; D007546:Isoquinolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D051379:Mice; D018091:Receptors, AMPA; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*
D018691:Excitatory Amino Acid Antagonists; D007546:Isoquinolines; D018091:Receptors, AMPA; D013777:Tetrazoles; C082309:tezampanel